Synonym |
MeOSuc-AAPV-AMC |
Species |
Human |
Protein Accession |
N/A |
Purity |
≥ 95% |
Endotoxin Level |
< 1 EU/μg |
Biological Activity |
N/A |
Expression System |
Chemical synthesis |
Fusion Tag |
N/A |
Predicted Molecular Mass |
1045.2 Da |
Formulation |
Supplied as a lyophilized powder |
Reconstitution |
Centrifuge vial before opening. Reconstitute in sterile ddH2O or aqueous buffer containing 0.1%
BSA to a concentration of 0.1-1.0 mg/ml. |
Storage & Stability |
Store at -20°C. Use within 12 months. |
FAQ
What is MeOSuc-AAPV-AMC and how does it work?
MeOSuc-AAPV-AMC is a sophisticated biochemical
compound commonly used in research settings, particularly in the study of biological processes involving
proteases. At its core, this compound functions as a substrate for specific types of proteases, which
are enzymes that break down proteins by cleaving the peptide bonds between amino acids. The unique
configuration of MeOSuc-AAPV-AMC allows it to serve as a fluorogenic substrate. This means that when the
substrate undergoes enzymatic cleavage by a protease, it releases a fluorescent signal that can be
detected and quantified. This fluorescent signal is pivotal for researchers as it provides a real-time
quantitative readout of protease activity.
The structure of MeOSuc-AAPV-AMC includes specific
amino acid sequences tailored to be recognized and cleaved by target proteases. Typically, these
sequences are crafted based on the specificity of the protease in question. In this case, the sequence
AAPV corresponds to the amino acids alanine, alanine, proline, and valine, which are specifically
recognized by certain proteases. Upon cleavage of the peptide bond in MeOSuc-AAPV-AMC, AMC
(4-methylcoumaryl-7-amide) is released, which is the fluorophore providing the visible
signal.
The research applications for MeOSuc-AAPV-AMC are vast, ranging from basic enzyme
activity assays to more advanced applications such as drug discovery and development. By providing a
robust method to measure protease activity, it enables the investigation of enzyme kinetics, inhibitor
screening, and diseases where proteases play a significant role. Furthermore, the fluorescence-based
detection allows for high-throughput screening, making it an invaluable tool for pharmaceutical
companies looking to evaluate the efficacy of potential therapeutic compounds. However, it is crucial to
interpret results correctly, understanding that factors such as enzyme concentration, incubation times,
and temperature can influence the outcome.
Are there any specific storage requirements for
MeOSuc-AAPV-AMC to ensure its longevity and efficacy?
Yes, MeOSuc-AAPV-AMC requires specific storage
conditions to maintain its stability and activity for consistent research outcomes. The compound is
sensitive to environmental conditions such as light, temperature, and humidity; thus, it's crucial to
handle and store it properly to preserve its functional integrity over time.
Firstly, one of the
most important storage conditions for MeOSuc-AAPV-AMC is temperature. This compound should be stored at
low temperatures, generally in the range of -20°C to -80°C, depending on the manufacturer's specific
recommendations. Low temperatures help reduce the rate of degradation reactions that can occur over
time, thereby prolonging the shelf life of the compound. When not in use, it should be kept in a tightly
sealed container within a freezer to prevent exposure to air and moisture, which can lead to hydrolysis
and disintegration of the substrate.
In addition to temperature control, protecting
MeOSuc-AAPV-AMC from light is also important. This compound is light-sensitive, and exposure to
ultraviolet or direct sunlight can lead to photodegradation, which can diminish its fluorescent
capabilities. For this reason, it is recommended to store the compound in an amber or opaque container,
or alternatively, in a dark place to minimize light exposure.
Another factor to consider is the
material of the storage container. It’s advisable to use containers made of materials that do not react
with the compound or allow for any leaching of impurities, which could compromise the compound’s purity
and effectiveness. Typically, glass or certain types of plastics approved for chemical storage are
considered suitable.
Furthermore, to extend the usability of MeOSuc-AAPV-AMC, aliquoting into
smaller volumes is a common strategy. By dividing the compound into smaller amounts, each aliquot can be
used entirely once thawed, avoiding repeated freeze-thaw cycles which could further degrade the
compound.
Because stability can vary based on concentration and formulation, following the
manufacturer's guidelines is critical for optimal storage and handling. By adhering to these storage
conditions, researchers can ensure they maintain the efficacy and reliability of MeOSuc-AAPV-AMC for
their experimental needs.
What are some common applications of MeOSuc-AAPV-AMC in scientific
research?
MeOSuc-AAPV-AMC is a versatile tool in scientific research, owing to its role as a
fluorogenic substrate for protease activity measurement. One of the primary applications of this
compound is in enzyme kinetics studies. Researchers use MeOSuc-AAPV-AMC to determine the dynamics of
enzymatic reactions involving specific proteases. By measuring the rate of fluorescence increase as the
substrate is cleaved, scientists can derive key kinetic parameters such as the rate constant (k),
Michaelis-Menten constant (Km), and maximum velocity (Vmax). This information is quintessential in
understanding the catalytic efficiency and mechanism of the proteases in biological
systems.
Another significant application is in drug discovery and development. Proteases are
critical enzymes involved in numerous physiological processes and diseases, including cancer,
inflammation, and infectious diseases. MeOSuc-AAPV-AMC allows researchers to screen potential protease
inhibitors by providing a real-time readout of enzyme activity. Inhibitory compounds that diminish the
fluorescence signal are identified as potential therapeutic agents. This high-throughput screening
capability is invaluable in early-phase drug development, enabling rapid assessment of thousands of
compounds for protease inhibition activity.
MeOSuc-AAPV-AMC is also utilized in the study of
apoptosis, the programmed cell death process. During apoptosis, certain proteases, like caspases, are
activated, leading to the cleavage of specific substrates. By employing MeOSuc-AAPV-AMC, researchers can
quantify the activity of these proteases in apoptotic pathways, contributing to a deeper understanding
of cell death mechanisms and identification of new targets for cancer therapy.
Additionally, it
finds applications in diagnostic development. MeOSuc-AAPV-AMC can be used to detect abnormal protease
activity linked to various diseases. For example, deviations in protease activity levels can be
indicative of diseases such as pancreatitis or chronic obstructive pulmonary disease (COPD). Therefore,
this compound can serve as a diagnostic reagent for monitoring disease progression or the efficacy of
therapeutic interventions.
Finally, MeOSuc-AAPV-AMC is used in environmental research. Proteases
play a significant role in microbial degradation processes within ecosystems. By assessing the activity
of these enzymes, researchers can gain insights into the functional dynamics of ecosystems, particularly
in response to pollutants or environmental changes. This helps in the development of strategies for
environmental protection and restoration.
What precautions should be taken when handling
MeOSuc-AAPV-AMC in the laboratory?
Handling MeOSuc-AAPV-AMC in the laboratory requires adherence to
strict safety protocols to ensure both personal safety and the integrity of the experiments being
conducted. Like many biochemical reagents, this compound poses risks if not handled properly, and
understanding these risks is essential.
Firstly, personal protective equipment (PPE) is a
paramount consideration. Wearing appropriate PPE, including lab coats, gloves, and protective eyewear,
is essential. Gloves are particularly important when handling MeOSuc-AAPV-AMC, as they prevent direct
skin contact. If contact does occur, it can lead to irritation or an allergic reaction in sensitive
individuals. Moreover, protective eyewear safeguards against accidental splashes that could cause eye
irritation.
Next, consider the work environment. MeOSuc-AAPV-AMC should be handled in a
well-ventilated area, such as a fume hood, to mitigate inhalation risks. Although the compound is not
highly volatile, working in a confined space increases the potential for inhalation of any encapsulated
particles or dust. Using a fume hood ensures that any aerosols or vapors are safely vented away from the
researcher, minimizing exposure.
Furthermore, maintaining the purity of MeOSuc-AAPV-AMC is
critical for reliable results. Cross-contamination is a serious concern in laboratory settings. To avoid
contamination, use dedicated pipette tips and tools when working with this substrate. Cleanliness and
organization in the workspace also play roles in preventing contamination. Spills should be cleaned
immediately using appropriate spill kits to avoid spreading the compound to other areas or
surfaces.
Additionally, it's important to follow waste disposal guidelines for chemical reagents.
MeOSuc-AAPV-AMC waste should be disposed of in accordance with institutional policies and local
regulations for hazardous chemical waste. This typically involves collection in designated containers
and cooperation with environmental health and safety departments to arrange for proper
disposal.
Finally, training and awareness are key components of safely handling MeOSuc-AAPV-AMC.
Laboratory personnel involved in experiments utilizing this compound should be thoroughly trained in its
handling, potential hazards, and safety protocols. Regular safety drills and availability of material
safety data sheets (MSDS) ensure that researchers remain informed about the safe use and handling of
MeOSuc-AAPV-AMC, thereby minimizing risks and enhancing experimental reliability.
Can
MeOSuc-AAPV-AMC be used in vivo, and what considerations should be made for such studies?
While
MeOSuc-AAPV-AMC is primarily used in vitro to assess protease activity, its application in vivo presents
unique challenges and considerations that must be diligently addressed to achieve meaningful and safe
results. The transition from in vitro to in vivo studies involves additional layers of complexity,
primarily due to the complex physiological environment in a living organism.
Firstly, the
pharmacokinetics of MeOSuc-AAPV-AMC should be thoroughly understood. In vivo systems involve cellular
uptake and metabolization, which can alter the distribution and concentration of the compound.
Researchers must determine the appropriate dosing schedules and delivery methods that consider variables
such as absorption, distribution, metabolism, and excretion. Routes of administration (e.g.,
intravenous, intraperitoneal) and formulation adjustments (e.g., encapsulation for sustained release)
may be necessary for effective delivery while minimizing any potential toxicity or side
effects.
Another important consideration is the compound’s specificity and stability in the
physiological environment. In vivo systems contain a myriad of biological molecules and different
enzymes, which may interact with MeOSuc-AAPV-AMC. Ensuring that the compound selectively interacts with
the targeted protease without significant off-target effects is vital. Additionally, the stability of
MeOSuc-AAPV-AMC is crucial, as its fluorogenic feature relies on the intact structure until proteolytic
cleavage. Modifications or protective measures, such as co-administration with stabilizing agents, might
be required to enhance its stability in vivo.
Moreover, ethical considerations and regulatory
compliance are critical aspects of in vivo studies. Studies using live organisms require ethical
approval and must comply with institutional guidelines and legal regulations concerning animal care and
use. Ethical oversight ensures that studies are justified, minimize animal usage, and adhere to humane
practices throughout the research.
Finally, the interpretation of results from in vivo studies
using MeOSuc-AAPV-AMC requires carefully controlled experimental conditions and comprehensive data
analysis. Researchers must account for biological variability and confirmatory studies with appropriate
controls to validate any findings related to protease activity in vivo. Calculated interpretation
ensures that researchers can confidently extrapolate in vitro findings to potential physiological
implications.
Each of these considerations underscores the importance of careful planning,
rigorous experimentation, and ethical responsibility when using MeOSuc-AAPV-AMC in vivo, ultimately
enriching our understanding of protease function in complex biological systems.